Christopher Boerner, PhD

Christopher Boerner, PhD, was appointed to succeed Giovanni Caforio, MD, as CEO of Bristol Myers Squibb effective November 1, 2023.

1 documented relationship

Hover or select an entity to isolate its relationships. Link thickness reflects the documented amount.

Detailed register

Christopher Boerner, PhDEmploymentBristol-Myers Squibb
November 1, 2023Reported^{2Bristol Myers Squibb Announces Leadership Transition Plantheglobeandmail.com}^{1Bristol Myers Squibb Announces Leadership Transition Plannews.bms.com}
Role or object indicated by the source: “CEO”.

Sources

1.
Bristol Myers Squibb Announces Leadership Transition Plan
Web pagenews.bms.com
View original ↑ Back to text
2.
Bristol Myers Squibb Announces Leadership Transition Plan
Web pagetheglobeandmail.com
View original ↑ Back to text